Brefeldin A inhibits vesicular MHC class I processing in resting but not in CpG- and disruption-activated DC

Molecular Immunology

Volumn 46, Issue 1, 2008, Pages 158-165

  Chen, Liying ^a   Jondal, Mikael ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cat S; DC; LAMP1; TLR; Vesicular MHC I processing

Indexed keywords

ARF PROTEIN; ASPARAGINE; BREFELDIN A; CATHEPSIN S; GLUTAMIC ACID; GUANOSINE DIPHOSPHATE; ISOLEUCINE; LEUCINE; LYSINE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MYELOID DIFFERENTIATION FACTOR 88; OVALBUMIN; PEPTIDE DERIVATIVE; PHENYLALANINE; SERINE; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BINDING SITE; CELL ACTIVATION; CELL COMPARTMENTALIZATION; CELL DISRUPTION; COMPLEX FORMATION; CONTROLLED STUDY; CPG ISLAND; CYTOSOL; DENDRITIC CELL; ENDOSOME; GOLGI COMPLEX; IMMUNOSTIMULATION; LYSOSOME; MEMBRANE TRANSPORT; MEMBRANE VESICLE; METABOLITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; BREFELDIN A; CATHEPSINS; CELL COMPARTMENTATION; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; MYELOID DIFFERENTIATION FACTOR 88; OLIGODEOXYRIBONUCLEOTIDES; OVALBUMIN; PEPTIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; SECRETORY VESICLES; VESICULAR TRANSPORT PROTEINS;

MUS;

EID: 52949126945     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.07.018     Document Type: Article

References (48)

1. Ackerman A.L., and Cresswell P. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5 (2004) 678-684
2. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., Nakanishi K., and Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9 (1998) 143-150
3. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 19 (1998) 245-252
4. Chen L., and Jondal M. Alternative processing for MHC class I presentation by immature and CpG-activated dendritic cells. Eur. J. Immunol. 34 (2004) 952-960
5. Chen L., and Jondal M. Endolysosomal processing of exogenous antigen into major histocompatibility complex class I-binding peptides. Scand. J. Immunol. 59 (2004) 545-552
6. Chen L., Fredholm B.B., and Jondal M. Adenosine, through the A(1) receptor, inhibits vesicular MHC class I cross-presentation by resting DC. Mol. Immunol. 45 (2008) 2247-2254
7. Delale T., Paquin A., Asselin-Paturel C., Dalod M., Brizard G., Bates E.E., and Kastner P. MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo. J. Immunol. 175 (2005) 6723-6732
8. Delamarre L., Holcombe H., and Mellman I. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J. Exp. Med. 198 (2003) 111-122
9. Deng Y., Bennink J.R., Kang H.C., Haugland R.P., and Yewdell J.W. Fluorescent conjugates of brefeldin A selectively stain the endoplasmic reticulum and Golgi complex of living cells. J. Histochem. Cytochem. 43 (1995) 907-915
10. D'Souza-Schorey C., and Chavrier P. ARF proteins: roles in membrane traffic and beyond. Nat. Rev. Mol. Cell Biol. 7 (2006) 347-358
11. Durand V., Wong S.Y., Tough D.F., and Le Bon A. Shaping of adaptive immune responses to soluble proteins by TLR agonists: a role for IFN-alpha/beta. Immunol. Cell Biol. 82 (2004) 596-602
12. Grembowicz K.P., Sprague D., and McNeil P.L. Temporary disruption of the plasma membrane is required for c-fos expression in response to mechanical stress. Mol. Biol. Cell 10 (1999) 1247-1257
13. Harding C.V. Class II antigen processing: analysis of compartments and functions. Crit. Rev. Immunol. 16 (1996) 13-29
14. Harding C.V., and Song R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153 (1994) 4925-4933
15. Heath W.R., and Carbone F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19 (2001) 47-64
16. Heit A., Schmitz F., Haas T., Busch D.H., and Wagner H. Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity. Eur. J. Immunol. 37 (2007) 2063-2074
17. Hogquist K.A., Jameson S.C., Heath W.R., Howard J.L., Bevan M.J., and Carbone F.R. T cell receptor antagonist peptides induce positive selection. Cell 76 (1994) 17-27
18. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Muramatsu S., and Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176 (1992) 1693-1702
19. Janeway Jr. C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54 (1989) 1-13
20. Jiang A., Bloom O., Ono S., Cui. W., Unternaehrer J., Jiang S., Whitney J.A., Connolly J., Banchereau J., and Mellman I. Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 27 (2007) 610-624
21. Karttunen J., Sanderson S., and Shastri N. Detection of rare antigen-presenting cells by the lacZ T cell activation assay suggests an expression cloning strategy for T cell antigens. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 6020-6024
22. Kawai T., and Akira S. TLR signalling. Cell Death Differ. 13 (2006) 816-825
23. Kavocsovics-Bankowski M., and Rock K.L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267 (1995) 243-246
24. Kurotaki T., Tamura Y., Ueda G., Oura J., Kutomi G., Hirohashi Y., Sahara H., Torigoe T., Hiratsuka H., Sunakawa H., Hirata K., and Sato N. Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway. J. Immunol. 179 (2007) 1803-1813
25. Lizee G., Basha G., Tiong J., Julien J.P., Tian M., Biron K.E., and Jefferies W.A. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nat. Immunol. 4 (2003) 1065-1073
26. Marleau A.M., and Sarvetnick N. T cell homeostasis in tolerance and immunity. J. Leukoc. Biol. 78 (2005) 575-584
27. Mellman I., and Steinman R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 106 (2001) 255-258
28. Mossessova E., Corpina R.A., and Goldberg J. Crystal structure of ARF1*Sec7 complexed with Brefeldin A and its implications for the guanine nucleotide exchange mechanism. Mol. Cell 12 (2003) 1403-1411
29. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12 (1994) 991-1045
30. Palliser D., Ploegh H., and Boes M. Myeloid differentiation factor 88 is required for cross-priming in vivo. J. Immunol. 172 (2004) 3415-3421
31. Pfeifer J.D., Wick M.J., Roberts R.L., Findlay K., Normark S.J., and Harding C.V. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361 (1993) 359-362
32. Porgador A., Yewdell J.W., Deng Y., Bennink J.R., and Germain R.N. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6 (1997) 715-726
33. Reis E., and Sousa C. Dendritic cells in a mature age. Nat. Rev. Immunol. 6 (2006) 476-483
34. Robineau S., Chabre M., and Antonny B. Binding site of brefeldin A at the interface between the small G protein ADP-ribosylation factor 1 (ARF1) and the nucleotide-exchange factor Sec7 domain. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 9913-9918
35. Rock K.L., Hearn A., Chen C.J., and Shi Y. Natural endogenous adjuvants. Springer Semin. Immunopathol. 26 (2005) 231-246
36. Scanga C., Aliberti A.J., Jankovic D., Tilloy F., Bennouna S., Denkers E.Y., and Medzhitov R. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 168 (2002) 5997-6001
37. Seya T., Akazawa T., Tsujita T., and Matsumoto M. Role of Toll-like receptors in adjuvant-augmented immune therapies. Evid Based Complement Altern. Med. 3 (2006) 31-38
38. Shen L., Sigal L.J., Boes M., and Rock K.L. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 21 (2004) 155-165
39. Shi G.P., Villadangos J.A., Dranoff G., Small C., Gu L., Haley K.J., and Riese R. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 10 (1999) 197-206
40. Steinman R.M., Hawiger D., Liu K., Bonifaz L., Bonnyay D., Mahnke K., and Iyoda T. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann. N. Y. Acad. Sci. 987 (2003) 15-25
41. Surh C.D., and Sprent J. Regulation of naive and memory T-cell homeostasis. Microbes Infect. 4 (2002) 51-56
42. Takeshita F., Gursel I., Ishii K.J., Suzuki K., Gursel M., and Klinman D.M. Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9. Semin. Immunol. 16 (2004) 17-22
43. Tiwari N., Garbi N., Reinheckel T., Moldenhauer G., Hämmerling G.J., and Momburg F. A transporter associated with antigen-processing independent vacuolar pathway for the MHC class I-mediated presentation of endogenous transmembrane proteins. J. Immunol. 178 (2007) 7932-7942
44. Trombetta E.S., Ebersold M., Garrett W., Pypaert M., and Mellman I. Activation of lysosomal function during dendritic cell maturation. Science 299 (2003) 1400-1403
45. Trombetta E.S., and Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu. Rev. Immunol. 23 (2005) 975-1028
46. van Duin D., Medzhitov R., and Shaw A.C. Triggering TLR signaling in vaccination. Trends Immunol. 27 (2006) 49-55
47. Van Kaer L., Ashton-Rickardt P.G., Ploegh H.L., and Tonegawa S. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell 71 (1992) 1205-1214
48. Yewdell J.W., Reits E., and Neefjes J. Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat. Rev. Immunol. 3 (2003) 952-961